Key result
Spinal cord stimulation yielded beneficial results in 70.6% of patients with severe atherosclerosis of the lower limbs who had failed or were ineligible for standard surgical treatment.
Why the study?
Does spinal cord stimulation improve clinical outcomes and cutaneous flow in patients with severe atherosclerosis of the lower limbs who are unsuitable for standard surgical treatment?
Observational (n=19)
Does spinal cord stimulation improve clinical outcomes and cutaneous flow in patients with severe atherosclerosis of the lower limbs who are unsuitable for standard surgical treatment?
Spinal cord stimulation may offer clinical benefits and increased cutaneous flow in patients with severe lower limb ischemia who are not candidates for standard surgical treatment, though randomized trials are needed.
May warrant consideration in refractory lower-limb ischemia; leaves open efficacy pending randomized trials.
Severe atherosclerosis of the lower limbs causes rest pain, skin ulcerations and gangrene. In such situations and when standard surgical treatment had failed or it is impossible to employ, spinal cord stimulation (SCS) seems to be of value. Since April 1985, we have used this technique on 19 patients. The results have been beneficial in 70.6% of the cases and have shown some evidence of increasing cutaneous flow. However, randomized series are required before accepting it as having a special place in the fight against atherosclerotic disease.
No takes yet. Share an insight, caveat, or question.
SAMPÈRE et al. (1989) conducted an observational in Severe atherosclerosis of the lower limbs (n=19). Spinal cord stimulation (SCS) was evaluated on Beneficial results. Spinal cord stimulation yielded beneficial results in 70.6% of patients with severe atherosclerosis of the lower limbs who had failed or were ineligible for standard surgical treatment.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: